In:
JHA - Journal of HIV and Ageing, Peperosso, ( 2023-06)
Abstract:
Human Immuno-deficiency Virus (HIV) infection and antiretroviral therapy (ART) are known independent risk factors for the development of metabolic disorders such as lipodystrophy, dyslipidemia and insulin resistance, bearing a greater risk for the development of type 2 diabetes mellitus. With the growing effectiveness of ART, HIV seropositivity is becoming a chronic disease, with a progressively increasing proportion of elderly people living with HIV (PLWH), exposing them to a significant age-related burden of morbidities, including diabetes. On these premises, PLWH should be considered subjects at high cardiovascular risk and coexisting diabetes should be properly treated. 〈 br / 〉 In this review the importance of a rapid diagnosis and an appropriate treatment of type 2 diabetes in PLWH is discussed, analyzing the available literature on the effect of anti-diabetic drugs in this selected population, focusing on the novel drugs with proven cardiovascular benefits.
Type of Medium:
Online Resource
ISSN:
2499-3638
,
2499-5819
Language:
Italian
Publisher:
Peperosso
Publication Date:
2023
Permalink
